"IMATIFLOW 400: Effective Cancer Treatment with Imatinib"

IMATIFLOW 400 

Imatinib IP (400mg)

Introduction

IMATIFLOW 400  is a combination Imatinib IP (400mg) is a targeted therapy used primarily in the treatment of certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). By inhibiting specific proteins that contribute to cancer growth, Imatinib helps to control and manage these conditions effectively.

What is Imatinib IP (400mg)? Imatinib is a tyrosine kinase inhibitor that works by blocking the activity of specific proteins (tyrosine kinases) that signal cancer cells to grow and divide. This action helps to slow or stop the growth of cancer cells, providing an effective treatment option for patients with certain types of leukemia and tumors.

Uses of Imatinib IP (400mg)

• Chronic Myeloid Leukemia (CML): Imatinib is widely used to treat CML, a type of cancer that affects the bone marrow and blood.
• Gastrointestinal Stromal Tumors (GIST): It is also effective in treating GIST, a type of tumor that occurs in the digestive tract.
• Other Cancers: Imatinib can be used to treat other cancers that involve abnormal tyrosine kinase activity, such as certain types of skin cancer and myelodysplastic/myeloproliferative diseases.

Dosage and Administration Imatinib IP (400mg) is usually taken once daily, with a meal and a large glass of water to reduce the risk of stomach upset. It is important to follow the prescribed dosage and not to skip doses to maintain effective blood levels of the medication.

Side Effects Common side effects include:

• Nausea and vomiting
• Diarrhea
• Muscle cramps
• Fatigue
• Swelling (edema)

Precautions and Warnings

• Regular blood tests are necessary to monitor blood counts and liver function while on Imatinib.
• Inform your healthcare provider about any other medications you are taking to avoid potential interactions.
• Pregnant women or those planning to become pregnant should avoid using Imatinib due to potential harm to the unborn baby.

Conclusion Imatinib IP (400mg) is a powerful targeted therapy for managing chronic myeloid leukemia and gastrointestinal stromal tumors. By inhibiting specific proteins that promote cancer growth, it offers an effective treatment option for patients with these conditions. Always consult your healthcare provider for personalized advice and follow the prescribed regimen for optimal results.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW